CHINARES PHARMA has completed the issuance of 1.5 billion RMB corporate bonds with an interest rate of 1.65%
CHINARES PHARMA (03320.HK) announced that its wholly-owned subsidiary, CHINARES PHARMA Holdings, has completed the issuance of 2026 corporate bonds (Phase I) with a principal amount of 1.5 billion RMB, a term of three years, and a coupon rate of 1.65%. The funds raised in this phase will be used for production-related expenditures
Source: AASTOCKS The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments